SACRED HEART MED CTR - UNIVERSITY — History
CCN 380033 | 3-year financial timeline | COVID resilience: 33/100
🛡️ Public data only — no PHI permitted on this instance.
$106M
Latest Revenue (FY2022)
-1.0%
Revenue CAGR (3yr)
-32.2%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $108M | $117M | $106M | -9.5% | -1.0% |
| Operating Expenses | $133M | $157M | $140M | -10.9% | +2.5% |
| Operating Margin | -23.4% | -34.3% | -32.2% | +6.1% | +0.0% |
| Net Income | $-25M | $-40M | $-34M | +15.0% | +0.0% |
| Licensed Beds | 36 | 36 | 36 | +0.0% | +0.0% |
| Total Patient Days | 3,315 | 3,096 | 2,604 | -15.9% | -11.4% |
| Medicare Day % | 34% | 31% | 10% | -68.0% | -46.2% |
| Medicaid Day % | 3% | 3% | 2% | -22.4% | -10.3% |
COVID Impact & Recovery
Resilience Score: 33/100 — Distressed — significant COVID damage
Revenue recovery from FY2020 to FY2022: -2.0% ($108M → $106M)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▼ Declining
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
-1.0%
This Hospital
+7.6%
State Avg
Latest Margin
-32.2%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $105M | -36.6% |
| FY2024 (proj) | $104M | -41.0% |
| FY2025 (proj) | $103M | -45.4% |